rs11573587

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_003738.5(PTCH2):​c.2127C>T​(p.Asp709Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,613,342 control chromosomes in the GnomAD database, including 335 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 21 hom., cov: 33)
Exomes 𝑓: 0.019 ( 314 hom. )

Consequence

PTCH2
NM_003738.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.912

Publications

7 publications found
Variant links:
Genes affected
PTCH2 (HGNC:9586): (patched 2) This gene encodes a transmembrane receptor of the patched gene family. The encoded protein may function as a tumor suppressor in the hedgehog signaling pathway. Alterations in this gene have been associated with nevoid basal cell carcinoma syndrome, basal cell carcinoma, medulloblastoma, and susceptibility to congenital macrostomia. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
PTCH2 Gene-Disease associations (from GenCC):
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • commissural facial cleft
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-44827646-G-A is Benign according to our data. Variant chr1-44827646-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 415453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.912 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0142 (2158/152312) while in subpopulation NFE AF = 0.0232 (1578/68024). AF 95% confidence interval is 0.0222. There are 21 homozygotes in GnomAd4. There are 1012 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2158 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCH2NM_003738.5 linkc.2127C>T p.Asp709Asp synonymous_variant Exon 15 of 22 ENST00000372192.4 NP_003729.3 Q9Y6C5-1
PTCH2NM_001166292.2 linkc.2127C>T p.Asp709Asp synonymous_variant Exon 15 of 23 NP_001159764.1 Q9Y6C5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCH2ENST00000372192.4 linkc.2127C>T p.Asp709Asp synonymous_variant Exon 15 of 22 1 NM_003738.5 ENSP00000361266.3 Q9Y6C5-1
PTCH2ENST00000447098.7 linkc.2127C>T p.Asp709Asp synonymous_variant Exon 15 of 23 1 ENSP00000389703.2 Q9Y6C5-2

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2158
AN:
152194
Hom.:
21
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00391
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0119
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.00659
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0232
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0134
AC:
3324
AN:
248898
AF XY:
0.0138
show subpopulations
Gnomad AFR exome
AF:
0.00303
Gnomad AMR exome
AF:
0.00868
Gnomad ASJ exome
AF:
0.0249
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00703
Gnomad NFE exome
AF:
0.0206
Gnomad OTH exome
AF:
0.0139
GnomAD4 exome
AF:
0.0186
AC:
27180
AN:
1461030
Hom.:
314
Cov.:
37
AF XY:
0.0184
AC XY:
13340
AN XY:
726800
show subpopulations
African (AFR)
AF:
0.00251
AC:
84
AN:
33480
American (AMR)
AF:
0.00877
AC:
392
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0279
AC:
728
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00588
AC:
507
AN:
86256
European-Finnish (FIN)
AF:
0.00709
AC:
373
AN:
52602
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5768
European-Non Finnish (NFE)
AF:
0.0217
AC:
24078
AN:
1111982
Other (OTH)
AF:
0.0165
AC:
998
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1784
3568
5352
7136
8920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2158
AN:
152312
Hom.:
21
Cov.:
33
AF XY:
0.0136
AC XY:
1012
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00390
AC:
162
AN:
41566
American (AMR)
AF:
0.0119
AC:
182
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.00600
AC:
29
AN:
4832
European-Finnish (FIN)
AF:
0.00659
AC:
70
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0232
AC:
1578
AN:
68024
Other (OTH)
AF:
0.0156
AC:
33
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
114
228
343
457
571
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0177
Hom.:
13
Bravo
AF:
0.0135
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Apr 01, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Basal cell carcinoma, susceptibility to, 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gorlin syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Basal cell nevus syndrome 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
3.5
DANN
Benign
0.87
PhyloP100
-0.91
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11573587; hg19: chr1-45293318; COSMIC: COSV100942217; API